BioPharma Services

Discovery to Diagnostics Pathway

AltheaDx is your partner for discovery, development and regulatory submission of new biomarkers for diagnosis and prognosis of disease.

AltheaDx Biomarker Capabilities

• Broad RNA expression profiling using Affymetrix® Microarrays:
  Reliably and reproducibly identifies critical gene sets
• Quantification via proprietary multiplexed XP-PCR:
  Sensitive, cost-effective measurement of biomarker gene panels
• "Blood to Blocks"
  Capable of analyzing a wide range of samples including blood, fresh frozen and FFPE tissues
• RNA-QC Assays to pre-qualify samples
  
• DNA genotyping: Identifies key mutations and SNPs
• Custom data analysis and expertise in all phases of cancer diagnostic development
  

AltheaDx Proprietary Biomarker Panels

• Diagnosis/prognosis of prostate cancer
• Diagnosis of childhood cancer
• Custom gene panels for targeted oncology therapeutics who knows